170 related articles for article (PubMed ID: 17182658)
1. Use of multiple displacement amplification in the investigation of human papillomavirus physical status.
Evans MF; Adamson CS; von Walstrom GM; Cooper K
J Clin Pathol; 2007 Oct; 60(10):1135-9. PubMed ID: 17182658
[TBL] [Abstract][Full Text] [Related]
2. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
3. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
4. Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa.
Badaracco G; Venuti A
Int J Oncol; 2005 Jul; 27(1):161-7. PubMed ID: 15942656
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two commercialised in situ hybridisation assays for detecting HPV-DNA in formalin-fixed, paraffin-embedded tissue.
Montag M; Blankenstein TJ; Shabani N; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Oct; 284(4):999-1005. PubMed ID: 21113720
[TBL] [Abstract][Full Text] [Related]
6. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
7. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions.
Das BC; Sharma JK; Gopalakrishna V; Luthra UK
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2327-36. PubMed ID: 1328489
[TBL] [Abstract][Full Text] [Related]
8. New molecular method for the detection of human papillomavirus type 16 integration.
Cañadas MP; Darwich L; Sirera G; Cirigliano V; Bofill M; Clotet B; Videla S;
Clin Microbiol Infect; 2010 Jul; 16(7):836-42. PubMed ID: 19840031
[TBL] [Abstract][Full Text] [Related]
9. Evidence of HPV16 integration in low- and high-grade cervical lesions that regress demonstrated by multiple displacement amplification and Southern blot hybridisation.
Evans MF; Adamson CS; Cooper K
J Clin Pathol; 2008 Apr; 61(4):541-3. PubMed ID: 18006667
[TBL] [Abstract][Full Text] [Related]
10. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
[TBL] [Abstract][Full Text] [Related]
11. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia.
Tate JE; Yang YC; Shen J; McLachlin CM; Sheets EE; Crum CP
Mol Cell Probes; 1996 Oct; 10(5):347-51. PubMed ID: 8910889
[TBL] [Abstract][Full Text] [Related]
12. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method.
Huang CC; Qiu JT; Kashima ML; Kurman RJ; Wu TC
Mod Pathol; 1998 Oct; 11(10):971-7. PubMed ID: 9796725
[TBL] [Abstract][Full Text] [Related]
13. Use of the polymerase chain reaction to specifically amplify integrated HPV-16 DNA by virtue of its linkage to interspersed repetitive DNA.
Carmody MW; Jones M; Tarraza H; Vary CP
Mol Cell Probes; 1996 Apr; 10(2):107-16. PubMed ID: 8737394
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
16. [Virological studies on generation of cervical carcinomas].
Yoshikawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):834-43. PubMed ID: 2172420
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
18. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus DNA is present in a subset of unselected breast cancers.
Liu Y; Klimberg VS; Andrews NR; Hicks CR; Peng H; Chiriva-Internati M; Henry-Tillman R; Hermonat PL
J Hum Virol; 2001; 4(6):329-34. PubMed ID: 12082399
[TBL] [Abstract][Full Text] [Related]
20. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
